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tp://dx.doi.org/10.1016/j.gendis.20Research misconduct in the field of medical science is on
the rise, according to two 2011 reports by Gautam Naik, a
science journalist for the Wall Street Journal 1,2. He re-
ported that the number of retracted scientific journal ar-
ticles had surged by 15-fold within the last decade, while
the number of publications had risen only 44%. A further
analysis within the same period showed that the rise in the
fraud-related retractions far exceeded the retractions due
to innocent errors. Naik pointed out that, although part of
the surge can be attributed to more vigilant journal editors,
as well as their advanced validation methods, competitive
researchers vying for the stagnant budget and a publication
environment preferring positive results may be the major
factors driving this trend. Naik further observed: “Science is
based on trust, and most researchers accept findings pub-
lished in peer-reviewed journals. The studies spur others
to embark on related avenues of research, so if one paper
is later found to be tainted, an entire edifice of work
comes into doubt. Millions of dollars’ worth of private and
government funding may go to waste, and, in the case of
medical science, patients can be put at risk.” It is apparent
that the vital interests of the research community, as well
as the trust of the general public, who are both the spon-
sors and beneficiaries of the scientific progress, are atity of Chongqing Medical
14.11.001stake. To turn the tide, the NIH and the journals Nature and
Science co-sponsored a workshop in June 2014 to propose
new Principles and Guidelines for reporting preclinical
research to ensure the transparency and durability of the
scientific findings (http://www.nih.gov/about/reporting-
preclinical-research.htm). Representatives from more
than 30 basic/preclinical science journals participated and
co-sponsored the proposed new guidelines. These newly
proposed publishing guidelines call for better disclosure of
information related to the experimental design, sample
collection and statistical data analysis, as well as for better
descriptions of the reagents and study materials, which are
expected to be shared among peer researchers after the
publication. Although the implementation of these guide-
lines remains challenging, this is a major step forward, with
many journal publishers united to raise the standards of
scientific publication.
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